Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2020

View Archived Issues

Enrollment ongoing in phase I/II study of oral BDTX-189 in advanced solid tumors

Sanofi initiates phase III study of SAR-408701 in CEACAM5-positive metastatic nonsquamous NSCLC

Novel muraminomicin derivatives with potent activity in MRSA infection models

OXi-4503 in combination with ARA-C shows safety and early clinical efficacy in AML

ASIT Biotech publishes phase III data for gp-ASIT+ grass allergen peptide immunotherapy

Suzhou Mednes Pharma Tech patents hedgehog signaling inhibitors

Roche discloses new EGFR mutant inhibitors

B cells help T cells succeed during checkpoint blockade

Single transcription factor enables chronic toxoplasma infection

AlzeCure Pharma presents Trk-A and/or Trk-B and/or Trk-C modulators

Meiji Seika Pharma describes new PDE4 inhibitors

New compounds for Huntington's disease presented by PTC Therapeutics

Pfizer begins phase III study of PF-06801591 in high-risk nonmuscle invasive bladder cancer

Xalud starts phase II study of XT-150 for pain due to knee osteoarthritis

SUMOylation inhibition enhances targeting of farnesoid X receptor for liver fibrosis

Kadmon discloses new SLC2A3 inhibitors

Oncogene Ras affects memory consolidation

Phase III study of surufatinib in pancreatic neuroendocrine tumors stopped early for efficacy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...